Goupille et al. describe an alternative approach targeting the host and tumoral primary metabolism in FLT3-mutant leukemia. Ketogenic diet strategies aiming to imbalance lipid homeostasis augment fatty acid and amino acid degradative activity, attenuating FLT3 signaling activation, cell proliferation, and leukemia progression upon targeted therapies.